Trade Secrets

China’s top court hands out record trade secrets award

The $25 million ruling comes in a clash between two of the world’s biggest producers of vanillin, a synthetic alternative to vanilla

China’s top court hands out record trade secrets award
What life sciences businesses need to know about data commercialisation
25 Feb 2021

What life sciences businesses need to know about data commercialisation

A strategy for protecting and exploiting data is now a must for entities involved in healthcare research

Seven top IP tips for biotech SMEs
18 Feb 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions


View all
17 Feb 2021

How SMEs can use IP to secure success in the new data-fuelled AI paradigm

The long read: Data does not have to be an opportunity just for the biggest players, smaller businesses can also get in on the act – but only if they think carefully about IP strategy Read more

12 Feb 2021

Ford CEO weighs in on “really embarrassing” South Korean battery trade secrets fight

With the auto giant set for a high-profile roll out of several new electric vehicles, the dispute between LG Chem and SK Innovation is once again in the spotlight Read more

1 Feb 2021

“It’s really embarrassing” - LG and SK feel the political heat ahead of US trade secrets decision

South Korean PM’s comments show that IP enforcement does not happen in a vacuum Read more

26 Jan 2021

Allergan’s Botox trade secrets win at the ITC underlines its growing importance in life sciences IP disputes

Victory for the US company and its Korean partner Medytox shows how Section 337 proceedings are becoming a vital enforcement tool for pharma and biotech rights owners Read more


View all
19 Nov 2020

Your guide to covid-19 vaccine stakeholders’ IP strategies

IAM examines the approaches taken by – and the issues facing – the leading companies in the race to find effective coronavirus inoculations Read more

9 Nov 2020

Pfizer’s covid vaccine found 90% effective, but raises IP questions

Company CEO proclaims “a great day for science and humanity”, but there are patent, know-how and data uncertainties to overcome Read more

28 Oct 2020

Help us to identify the world's leading IP strategists

The research process for the IAM Strategy 300 2021 is now underway and we are inviting nominations as we decide who should be included Read more

24 Oct 2020

To educate lawyers who change the world, we cannot let this crisis go to waste

As the covid-19 pandemic continues to upend education in the US and beyond, there is an opportunity to create a new normal in how IP is taught, says Megan Carpenter, Dean of the Franklin Pierce School of Law Read more


View all
13 Jan 2021

Why F1 teams need to do more with IP

Many are looking for opportunities to expand their technology into other areas of the auto sector, but to do so effectively a greater focus on patents is essential Read more

7 Jan 2021

Surprise change to FDA Purple Book creates risks and opportunities for biosimilar producers

A US patent transparency amendment has mixed implications for the strategies pursued by biologics copycat producers Read more

4 Jan 2021

All the China IP stories you missed over the holidays

Wuhan injunction drama was far from the only big IP news to come out of China over the festive period Read more

22 Dec 2020

Three life sciences trade secrets and data strategy lessons

As non-patent assets become increasingly important, pharma and biotech innovators must adapt their IP strategies. Read more


View all
8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more

Find an expert

Gunars Gaikis
Of Counsel
Toronto ON, Canada
Smart & Biggar